OPPICI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 2.134
EU - Europa 1.872
AS - Asia 1.637
SA - Sud America 205
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.892
Nazione #
US - Stati Uniti d'America 2.093
RU - Federazione Russa 789
CN - Cina 621
SG - Singapore 555
GB - Regno Unito 376
IT - Italia 177
BR - Brasile 166
VN - Vietnam 148
HK - Hong Kong 129
SE - Svezia 108
FR - Francia 85
DE - Germania 84
IE - Irlanda 78
FI - Finlandia 62
KR - Corea 50
IN - India 30
BE - Belgio 22
JP - Giappone 22
CA - Canada 21
UA - Ucraina 21
ID - Indonesia 15
NL - Olanda 15
AR - Argentina 13
BD - Bangladesh 13
ES - Italia 13
NG - Nigeria 13
IQ - Iraq 12
PL - Polonia 12
EC - Ecuador 9
TR - Turchia 9
ZA - Sudafrica 9
MX - Messico 8
PK - Pakistan 8
AT - Austria 5
GR - Grecia 5
VE - Venezuela 5
LT - Lituania 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LV - Lettonia 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
LU - Lussemburgo 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 5.892
Città #
Southend 313
Singapore 287
Moscow 254
Chandler 251
Dallas 243
Ashburn 217
San Jose 189
Woodbridge 138
Ann Arbor 132
Hong Kong 126
Beijing 122
Verona 110
Jacksonville 106
Dublin 78
The Dalles 59
Jinan 52
New York 45
Ho Chi Minh City 42
Houston 39
Nanjing 38
Lawrence 33
Los Angeles 33
Princeton 33
Shenyang 32
Hanoi 31
Hebei 30
Wilmington 29
Columbus 23
Tianjin 23
Haikou 21
São Paulo 21
Brussels 20
Seattle 20
Zhengzhou 20
Tokyo 19
Ningbo 18
Helsinki 17
Buffalo 16
Changsha 16
Council Bluffs 16
Santa Clara 16
Seoul 16
Munich 15
Nanchang 14
Taizhou 14
Dong Ket 13
Hangzhou 13
Guangzhou 12
Lanzhou 12
Milan 12
Abuja 11
Jakarta 11
Montreal 11
Redondo Beach 11
San Francisco 11
Stockholm 11
Belo Horizonte 10
Boardman 10
Chennai 10
Fuzhou 9
Jiaxing 9
Taiyuan 9
Brooklyn 8
Warsaw 8
Amsterdam 7
Da Nang 7
Denver 7
Kent 7
London 7
Norwalk 7
Orem 7
Frankfurt am Main 6
Johannesburg 6
Phoenix 6
Redwood City 6
Boston 5
Dearborn 5
Mumbai 5
Quito 5
Redmond 5
Athens 4
Atlanta 4
Biên Hòa 4
Cagliari 4
Falkenstein 4
Lancaster 4
Perugia 4
Qingdao 4
Rio de Janeiro 4
Riva 4
Auburn Hills 3
Baghdad 3
Caserta 3
Chicago 3
Detroit 3
Erbil 3
Falls Church 3
Fortaleza 3
Ha Long 3
Hyderabad 3
Totale 3.756
Nome #
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 298
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 259
Molecular and cellular insights into defects of human alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I 221
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 220
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 204
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 202
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 201
Folding defects leading to primary hyperoxaluria 200
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 198
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 196
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 191
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 191
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 189
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 189
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 185
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 180
Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6 176
Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia 173
Dimerization drives proper folding of human Alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 172
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 170
Evolutionary divergent suppressor mutations in conformational diseases 166
Biochemical properties and oxalate-degrading activity of oxalate decarboxylase from Bacillus Subtilis at neutral pH 165
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 164
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 162
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 154
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 152
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 150
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 149
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 149
Molecular basis of primary hyperoxaluria: clues to innovative treatments 146
A novel p.(Glu111Val) missense mutation in GUCA1A associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors 138
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 122
Molecular insights into primary hyperoxaluria Type I pathogenesis. 119
Totale 5.951
Categoria #
all - tutte 17.574
article - articoli 15.811
book - libri 0
conference - conferenze 675
curatela - curatele 0
other - altro 540
patent - brevetti 0
selected - selezionate 0
volume - volumi 548
Totale 35.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 6 35 24
2021/2022339 28 142 28 9 7 3 6 20 16 8 12 60
2022/2023660 40 88 54 118 62 135 15 41 70 1 21 15
2023/2024262 16 13 11 15 30 50 5 35 5 15 48 19
2024/2025842 41 49 22 138 69 31 66 29 150 51 74 122
2025/20262.498 176 95 285 370 685 198 204 131 194 160 0 0
Totale 5.951